AQR Capital Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-13,633
| Closed | -$565K | – | 2281 |
|
2020
Q3 | $565K | Sell |
13,633
-6,151
| -31% | -$255K | ﹤0.01% | 1664 |
|
2020
Q2 | $948K | Buy |
19,784
+1,415
| +8% | +$67.8K | ﹤0.01% | 1477 |
|
2020
Q1 | $1.16M | Sell |
18,369
-1,983
| -10% | -$125K | ﹤0.01% | 1275 |
|
2019
Q4 | $2.52M | Sell |
20,352
-4,218
| -17% | -$523K | ﹤0.01% | 1183 |
|
2019
Q3 | $1.63M | Sell |
24,570
-7,934
| -24% | -$526K | ﹤0.01% | 1358 |
|
2019
Q2 | $2.59M | Sell |
32,504
-3
| -0% | -$239 | ﹤0.01% | 1180 |
|
2019
Q1 | $3.64M | Buy |
32,507
+211
| +0.7% | +$23.6K | ﹤0.01% | 1096 |
|
2018
Q4 | $3.26M | Buy |
32,296
+10,419
| +48% | +$1.05M | ﹤0.01% | 1078 |
|
2018
Q3 | $2.76M | Buy |
+21,877
| New | +$2.76M | ﹤0.01% | 1250 |
|
2016
Q1 | – | Sell |
-9,247
| Closed | -$1.38M | – | 2301 |
|
2015
Q4 | $1.38M | Buy |
+9,247
| New | +$1.38M | ﹤0.01% | 1435 |
|
2015
Q3 | – | Sell |
-3,999
| Closed | -$965K | – | 2282 |
|
2015
Q2 | $965K | Buy |
3,999
+799
| +25% | +$193K | ﹤0.01% | 1508 |
|
2015
Q1 | $902K | Sell |
3,200
-3,700
| -54% | -$1.04M | ﹤0.01% | 1465 |
|
2014
Q4 | $1.08M | Sell |
6,900
-17,700
| -72% | -$2.76M | ﹤0.01% | 1609 |
|
2014
Q3 | $5.82M | Buy |
24,600
+16,757
| +214% | +$3.97M | 0.02% | 767 |
|
2014
Q2 | $1.86M | Buy |
7,843
+2,700
| +52% | +$639K | 0.01% | 1323 |
|
2014
Q1 | $1.7M | Sell |
5,143
-1,600
| -24% | -$528K | 0.01% | 1403 |
|
2013
Q4 | $460K | Buy |
+6,743
| New | +$460K | ﹤0.01% | 2107 |
|
2013
Q3 | – | Sell |
-25,000
| Closed | -$1.12M | – | 2549 |
|
2013
Q2 | $1.12M | Buy |
+25,000
| New | +$1.12M | ﹤0.01% | 1514 |
|